• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014-2017 年德国基于人群的儿童和青少年甲型肝炎血清流行率、疫苗接种状况和人口统计学决定因素研究。

Hepatitis A seroprevalence, vaccination status and demographic determinants in children and adolescents in Germany, 2014-2017, a population-based study.

机构信息

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

出版信息

Sci Rep. 2023 Jun 16;13(1):9762. doi: 10.1038/s41598-023-36739-4.

DOI:10.1038/s41598-023-36739-4
PMID:37328526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10275889/
Abstract

Children play an important role in hepatitis A virus (HAV) transmission but, due to frequent asymptomatic or mild courses, these infections are underrecognized in routine surveillance. Here, we analyzed hepatitis A (HA) seroprevalence, vaccination status and demographic determinants and estimated previous HAV infections in a cross-sectional population-based study of children and adolescents with residence in Germany 2014-2017, performing weighted univariable and multivariable logistic regression. Of 3567 participants aged 3-17 years, serological results were available for 3013 (84.5%), vaccination records for 3214 (90.1%) and both for 2721 (76.3%). Of 2721 with complete results, 467 (17.2%) were seropositive, thereof 412 (15.1%) with and 55 (2.0%) without previous HA vaccination, indicating previous HAV infection. Seropositivity was associated with age, residence in Eastern states, high socioeconomic status and migration background with personal migration experience. Participants with migration background and personal migration experience also had the highest odds ratios for previous HAV infection. Germany remains a country with very low HA endemicity. The current vaccination recommendations focusing on individuals with a high risk for HAV exposure (e.g. travelers to endemic countries) or severe disease appear appropriate. Migration and travel patterns as well as the endemicity in other countries influence the domestic situation, warranting further monitoring.

摘要

儿童在甲型肝炎病毒(HAV)传播中发挥着重要作用,但由于其经常无症状或症状较轻,这些感染在常规监测中容易被忽视。在此,我们分析了 2014-2017 年期间居住在德国的儿童和青少年的甲型肝炎(HA)血清流行率、疫苗接种状况和人口统计学决定因素,并估计了他们之前的 HAV 感染情况,通过加权单变量和多变量逻辑回归进行了分析。在 3567 名年龄在 3-17 岁的参与者中,有 3013 名(84.5%)的血清学结果可用,3214 名(90.1%)的疫苗接种记录可用,2721 名(76.3%)两者都有。在 2721 名有完整结果的参与者中,有 467 名(17.2%)呈血清阳性,其中 412 名(15.1%)有和 55 名(2.0%)无之前的 HA 疫苗接种史,表明之前感染过 HAV。血清阳性与年龄、居住在东部各州、高社会经济地位和移民背景以及个人移民经历有关。具有移民背景和个人移民经历的参与者之前感染 HAV 的可能性也最高。德国仍然是一个甲型肝炎低度流行的国家。目前的疫苗接种建议侧重于那些有 HAV 暴露高风险(例如前往流行地区的旅行者)或有严重疾病风险的个体,这种做法似乎是恰当的。移民和旅行模式以及其他国家的流行情况影响着国内形势,需要进一步监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0503/10275889/15c1e93b4df1/41598_2023_36739_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0503/10275889/a12941e77171/41598_2023_36739_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0503/10275889/15c1e93b4df1/41598_2023_36739_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0503/10275889/a12941e77171/41598_2023_36739_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0503/10275889/15c1e93b4df1/41598_2023_36739_Fig2_HTML.jpg

相似文献

1
Hepatitis A seroprevalence, vaccination status and demographic determinants in children and adolescents in Germany, 2014-2017, a population-based study.2014-2017 年德国基于人群的儿童和青少年甲型肝炎血清流行率、疫苗接种状况和人口统计学决定因素研究。
Sci Rep. 2023 Jun 16;13(1):9762. doi: 10.1038/s41598-023-36739-4.
2
Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany.德国儿童和青少年甲型肝炎病毒感染、免疫接种和人口统计学决定因素。
Sci Rep. 2018 Nov 12;8(1):16696. doi: 10.1038/s41598-018-34927-1.
3
Hepatitis A seroprevalence and demographic risk factors in the susceptible population: a cross-sectional study.甲型肝炎血清流行率及易感人群的人口统计学危险因素:一项横断面研究。
Eur Rev Med Pharmacol Sci. 2023 Jun;27(11):4936-4941. doi: 10.26355/eurrev_202306_32610.
4
Epidemiologic patterns of hepatitis A infection during the pre-vaccination era: A population-based survey in Tunisia in 2015.甲型肝炎感染的流行病学模式在疫苗接种前时代:2015 年在突尼斯进行的一项基于人群的调查。
Int J Infect Dis. 2022 Apr;117:162-168. doi: 10.1016/j.ijid.2022.01.004. Epub 2022 Jan 8.
5
Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.在墨西哥进行的一项横断面研究中甲型肝炎病毒的血清流行率:对甲型肝炎疫苗接种的影响。
Hum Vaccin Immunother. 2013 Feb;9(2):375-81. doi: 10.4161/hv.22774. Epub 2013 Jan 4.
6
Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran.甲型肝炎病毒免疫:来自伊朗的全国性基于人群的血清流行率研究。
Vaccine. 2020 Oct 21;38(45):7100-7107. doi: 10.1016/j.vaccine.2020.08.071. Epub 2020 Sep 9.
7
Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: an implication for hepatitis A immunization.泰国北部儿童和青少年甲型肝炎病毒抗体的血清流行率:甲型肝炎免疫接种的意义。
Sci Rep. 2023 Oct 13;13(1):17432. doi: 10.1038/s41598-023-44643-0.
8
Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors.波兰大波兰地区成年居民甲型肝炎病毒抗体(抗-HAV)的血清流行率——简单人口统计学因素的作用
Ann Agric Environ Med. 2012;19(4):738-41.
9
Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.甲型肝炎疫苗接种率在前往高或中度流行地区的 18-49 岁成年人中,美国。
Vaccine. 2013 May 1;31(19):2348-57. doi: 10.1016/j.vaccine.2013.03.011. Epub 2013 Mar 21.
10
Hepatitis A in the Eastern Mediterranean Region: a comprehensive review.《东地中海区域的甲型肝炎:全面综述》
Hum Vaccin Immunother. 2022 Nov 30;18(5):2073146. doi: 10.1080/21645515.2022.2073146. Epub 2022 May 26.

本文引用的文献

1
New data for action. Data collection for KiGGS Wave 2 has been completed.采取行动的新数据。德国儿童青少年健康监测与促进项目(KiGGS)第二轮的数据收集工作已经完成。
J Health Monit. 2017 Sep 27;2(Suppl 3):2-27. doi: 10.17886/RKI-GBE-2017-105. eCollection 2017 Sep.
2
Socioeconomic status and subjective social status measurement in KiGGS Wave 2.德国儿童青少年健康访谈与检查调查(KiGGS)第二轮中的社会经济地位和主观社会地位测量
J Health Monit. 2018 Mar 15;3(1):108-125. doi: 10.17886/RKI-GBE-2018-033. eCollection 2018 Mar.
3
Improving the inclusion and participation of children and adolescents with a migration background in KiGGS Wave 2.
在德国儿童青少年健康访谈与检查调查(KiGGS)第二轮中提高有移民背景的儿童和青少年的纳入率及参与度。
J Health Monit. 2018 Mar 15;3(1):126-142. doi: 10.17886/RKI-GBE-2018-034. eCollection 2018 Mar.
4
KiGGS Wave 2 cross-sectional study - participant acquisition, response rates and representativeness.德国儿童青少年健康监测与促进项目第二轮横断面研究——参与者招募、应答率及代表性
J Health Monit. 2018 Mar 15;3(1):78-91. doi: 10.17886/RKI-GBE-2018-032. eCollection 2018 Mar.
5
Hepatitis A Vaccine Effectiveness and Seropositivity Among 1- to 18-Year-Old Children: 10-Year Results.1至18岁儿童的甲型肝炎疫苗效力和血清阳性率:10年结果
Turk Arch Pediatr. 2022 Mar;57(2):205-209. doi: 10.5152/TurkArchPediatr.2022.21194.
6
Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.甲型肝炎疫苗接种及其免疫和流行病学的长期效果——证据综述。
Hum Vaccin Immunother. 2021 May 4;17(5):1496-1519. doi: 10.1080/21645515.2020.1819742. Epub 2020 Dec 16.
7
Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from Panama.甲型肝炎抗体持久性:巴拿马儿童接种 1 剂和 2 剂疫苗后 8 年和 10 年的研究
Vaccine. 2021 Jan 3;39(1):26-34. doi: 10.1016/j.vaccine.2020.11.030. Epub 2020 Nov 22.
8
Resurgence of an international hepatitis A outbreak linked to imported frozen strawberries, Germany, 2018 to 2020.2018 年至 2020 年德国与进口冷冻草莓相关的国际甲型肝炎暴发疫情复燃
Euro Surveill. 2020 Sep;25(37). doi: 10.2807/1560-7917.ES.2020.25.37.1900670.
9
Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned.希腊过去十年甲型肝炎的流行病学:报告病例和暴发的管理以及经验教训。
Epidemiol Infect. 2020 Feb 13;148:e58. doi: 10.1017/S0950268820000382.
10
Factors That Influence the Immune Response to Vaccination.影响疫苗免疫反应的因素。
Clin Microbiol Rev. 2019 Mar 13;32(2). doi: 10.1128/CMR.00084-18. Print 2019 Mar 20.